Polyox Wsr 303

FORMULATION AND EVALUATION OF ONCE A DAY REGIOSELECTIVE DUAL

FORMULATION AND EVALUATION OF ONCE A DAY REGIOSELECTIVE DUAL

Development and Characterization of Compression-Coated Tablet of

Development and Characterization of Compression-Coated Tablet of

Differential scanning calorimetry curves of Polyox WSR 303 and N-12K

Differential scanning calorimetry curves of Polyox WSR 303 and N-12K

Development of a controlled release low dose class II drug-Glipizide

Development of a controlled release low dose class II drug-Glipizide

Academic OneFile - Document - Application of design of experiment

Academic OneFile - Document - Application of design of experiment

FORMULATION AND DEVELOPMENT OF pH INDEPENDENT ONCE DAILY MATRIX

FORMULATION AND DEVELOPMENT OF pH INDEPENDENT ONCE DAILY MATRIX

Polyox (Polyethylene Oxide) Multifunctional Polymer in Novel Drug

Polyox (Polyethylene Oxide) Multifunctional Polymer in Novel Drug

ORAL SUSTAINED DELIVERY OF GASTROPROKINETIC DRUG MOSAPRIDE CITRATE

ORAL SUSTAINED DELIVERY OF GASTROPROKINETIC DRUG MOSAPRIDE CITRATE

POLYOX Water-Soluble Resins NF in Pharmaceutical Applications

POLYOX Water-Soluble Resins NF in Pharmaceutical Applications

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

POLYOX Water-Soluble Resins NF in Pharmaceutical Applications

POLYOX Water-Soluble Resins NF in Pharmaceutical Applications

Development and Optimization of Venlafaxine Hydrochloride Sustained

Development and Optimization of Venlafaxine Hydrochloride Sustained

Shear-Thinning Rheology of the Abuse-Deterrent Dosage Form Extracts

Shear-Thinning Rheology of the Abuse-Deterrent Dosage Form Extracts

Journal of Drug Delivery and Therapeutics

Journal of Drug Delivery and Therapeutics

Figure 2 from Tracking the physical aging of poly(ethylene oxide): A

Figure 2 from Tracking the physical aging of poly(ethylene oxide): A

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

Evaluation of the drug solubility and rush ageing on drug release

Evaluation of the drug solubility and rush ageing on drug release

POLYOX WSR COAGULANT (Полиэтиленоксид ульравысокомолекулярный): продажа,  цена в Украине

POLYOX WSR COAGULANT (Полиэтиленоксид ульравысокомолекулярный): продажа, цена в Украине

The Pharmaceutical and Chemical Journal, 2016, 3(2):207-220 Research

The Pharmaceutical and Chemical Journal, 2016, 3(2):207-220 Research

Measurement of the polymer swelling kinetics, comparison of two

Measurement of the polymer swelling kinetics, comparison of two

Sustained drug release profiles from three-layered tablets

Sustained drug release profiles from three-layered tablets

Novel Combinations of Rate-Controlling Polymers for the Release of

Novel Combinations of Rate-Controlling Polymers for the Release of

US 2009/0017121 A1 - Gastric Retained Gabapentin Dosage Form - The

US 2009/0017121 A1 - Gastric Retained Gabapentin Dosage Form - The

FORMULATION AND EVALUATION OF AN ANTIMICROBIAL DRUG LOADED HYDROGEL

FORMULATION AND EVALUATION OF AN ANTIMICROBIAL DRUG LOADED HYDROGEL

International Journal of Pharmaceutical Sciences and Drug Research

International Journal of Pharmaceutical Sciences and Drug Research

WO2016136849A1 - Solid preparation - Google Patents

WO2016136849A1 - Solid preparation - Google Patents

Formulation and Evaluation of Sustained Release Matrix Tablets of

Formulation and Evaluation of Sustained Release Matrix Tablets of

GASTRIC RETENTION AND CONTROLLED RELEASE DELIVERY SYSTEM - Patent

GASTRIC RETENTION AND CONTROLLED RELEASE DELIVERY SYSTEM - Patent

FORMULATION AND EVALUATION OF AN ANTIMICROBIAL DRUG LOADED HYDROGEL

FORMULATION AND EVALUATION OF AN ANTIMICROBIAL DRUG LOADED HYDROGEL

Valacyclovir hydrochloride | CAS:124832-27-5 For Research Use | High

Valacyclovir hydrochloride | CAS:124832-27-5 For Research Use | High

Figure 4 from Formulation and evaluation of bilayer floating tablets

Figure 4 from Formulation and evaluation of bilayer floating tablets

Effect of Formulation and Granulation Processing Parameters on

Effect of Formulation and Granulation Processing Parameters on

DEVELOPMENT OF GASTRORETENTIVE FLOATING TABLETS OF DILTIAZEM

DEVELOPMENT OF GASTRORETENTIVE FLOATING TABLETS OF DILTIAZEM

Development and Characterization of Compression-Coated Tablet of

Development and Characterization of Compression-Coated Tablet of

Differential scanning calorimetry curves of Polyox WSR 303 and N-12K

Differential scanning calorimetry curves of Polyox WSR 303 and N-12K

WORLD JOURNAL OF PHARMACEUTICAL RESEARCH

WORLD JOURNAL OF PHARMACEUTICAL RESEARCH

Evaluations of the Effect of Sodium Metabisulphite on the Stability

Evaluations of the Effect of Sodium Metabisulphite on the Stability

WO2011122524A1 - Controlled release pharmaceutical composition

WO2011122524A1 - Controlled release pharmaceutical composition

Preparation and In-vivo Pharmacokinetic Study of a Novel Extended

Preparation and In-vivo Pharmacokinetic Study of a Novel Extended

Polyox Form Peo Matrices | Tablet (Pharmacy) | Pharmaceutical

Polyox Form Peo Matrices | Tablet (Pharmacy) | Pharmaceutical

Polyox Form Peo Matrices | Tablet (Pharmacy) | Pharmaceutical

Polyox Form Peo Matrices | Tablet (Pharmacy) | Pharmaceutical

Research Article CODEN: IJPRNK ISSN: 2277-8713

Research Article CODEN: IJPRNK ISSN: 2277-8713

Sustained drug release profiles from three-layered tablets

Sustained drug release profiles from three-layered tablets

Measurement of the polymer swelling kinetics, comparison of two

Measurement of the polymer swelling kinetics, comparison of two

Effect of Polyethylene Oxide Molecular Weight and Osmogen Content on

Effect of Polyethylene Oxide Molecular Weight and Osmogen Content on

Evaluations of the Effect of Sodium Metabisulphite on the Stability

Evaluations of the Effect of Sodium Metabisulphite on the Stability

Design & Characterization of Timolol Maleate Osmotic Drug Delivery

Design & Characterization of Timolol Maleate Osmotic Drug Delivery

Effect of aqueous solubility of drug on its release from PEO

Effect of aqueous solubility of drug on its release from PEO

FORMULATION AND EVALUATION OF ONCE A DAY REGIOSELECTIVE DUAL

FORMULATION AND EVALUATION OF ONCE A DAY REGIOSELECTIVE DUAL

The Pharmaceutical and Chemical Journal, 2016, 3(2):207-220 Research

The Pharmaceutical and Chemical Journal, 2016, 3(2):207-220 Research

View of PREPARATION AND EVALUATION OF FLOATING EXTENDED RELEASE

View of PREPARATION AND EVALUATION OF FLOATING EXTENDED RELEASE

POLYOX Water-Soluble Resins NF in Pharmaceutical Applications

POLYOX Water-Soluble Resins NF in Pharmaceutical Applications

POLYETHYLENE OXIDES Analysis of tablet formation and properties of

POLYETHYLENE OXIDES Analysis of tablet formation and properties of

Evaluation of the drug solubility and rush ageing on drug release

Evaluation of the drug solubility and rush ageing on drug release

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

Design, development and evaluation of Lornoxicam sustained release

Design, development and evaluation of Lornoxicam sustained release

Evaluation of the drug solubility and rush ageing on drug release

Evaluation of the drug solubility and rush ageing on drug release

WORLD JOURNAL OF PHARMACEUTICAL RESEARCH

WORLD JOURNAL OF PHARMACEUTICAL RESEARCH

Design, development and evaluation of Lornoxicam sustained release

Design, development and evaluation of Lornoxicam sustained release

Measurement of the polymer swelling kinetics, comparison of two

Measurement of the polymer swelling kinetics, comparison of two

Preparation and in vitro characterization of non-effervescent

Preparation and in vitro characterization of non-effervescent

POLYOX  Application Data  Formulation of POLYOX ER Matrices for a

POLYOX Application Data Formulation of POLYOX ER Matrices for a

FORMULATION AND DEVELOPMENT OF pH INDEPENDENT ONCE DAILY MATRIX

FORMULATION AND DEVELOPMENT OF pH INDEPENDENT ONCE DAILY MATRIX

WO 2004/014346 A1 - Palatable Controlled-release Formulation For

WO 2004/014346 A1 - Palatable Controlled-release Formulation For

Polyethylene oxides: protection potential against polymorphic

Polyethylene oxides: protection potential against polymorphic

Sustained drug release profiles from three-layered tablets

Sustained drug release profiles from three-layered tablets

Purchase Order No : 4532001893 Date of 10 11 2017

Purchase Order No : 4532001893 Date of 10 11 2017

PEO hot melt extrudates for controlled drug delivery

PEO hot melt extrudates for controlled drug delivery

FORMULATION AND EVALUATION OF ONCE A DAY REGIOSELECTIVE DUAL

FORMULATION AND EVALUATION OF ONCE A DAY REGIOSELECTIVE DUAL

POLYOX TM Water Soluble Resins Combining Flexibility with Consistency

POLYOX TM Water Soluble Resins Combining Flexibility with Consistency

Assessing impact of formulation and process variables on in-vitro

Assessing impact of formulation and process variables on in-vitro

FORMULATION AND DEVELOPMENT OF KETOPROFEN BILAYER TABLETS Nagesh D R

FORMULATION AND DEVELOPMENT OF KETOPROFEN BILAYER TABLETS Nagesh D R

Sustained drug release profiles from three-layered tablets

Sustained drug release profiles from three-layered tablets

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION - Patent 2345410

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION - Patent 2345410

Optimization of floating bilayered tablets of Ketorolac Tromethamine

Optimization of floating bilayered tablets of Ketorolac Tromethamine

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION

FORMULATION DEVELOPMENT, CHARACTERIZATION, AND IN VITRO EVALUATION